NCT02601586 - Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions

Parkinson Disease

Interventions

DRUG

PR Oxycodone

DRUG

Levodopa

DRUG

Oxycodone Placebo

Placebo of PR Oxycodone

DRUG

Levodopa placebo

Trial Locations (18)

13385

University Hospital of Marseille, Marseille

13616

Hospital of Aix-en-Provence, Aix-en-Provence

31059

Chu Toulouse, Toulouse

33076

University Hospital of Bordeaux, Bordeaux

35033

University Hospital of Rennes, Rennes

59037

University Hospital of Lille, Lille

63003

University Hospital of Clermont-Ferrand, Clermont-Ferrand

67098

University Hospital of Strasbourg, Strasbourg

75651

Pitié-Salpêtrière Hospital, Paris

76031

University Hospital of Rouen, Rouen

80054

CHU Amiens, Amiens

86021

University Hospital of Poitiers, Poitiers

87042

University Hospital of Limoges, Limoges

94010

Henri Mondor Hospital, Créteil

Unknown

Hospital Pierre Wertheimer, Lyon

University Hospital of Nancy, Nancy

University Hospital of Nantes, Nantes

University Hospital of Nîmes - Caremeau, Nîmes

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER